BamSEC and AlphaSense Join Forces
Learn More

Portola Pharmaceuticals Inc

Formerly NASDAQ: PTLA

Material Contracts Filter

EX-10.53
from 10-Q ~5 pages December 19, 2019 Rajiv Patni via Email Annual Salary Your Salary Will Be Paid at the Rate of $40,833.33 Per Month ($490,000.00 Annualized) Less Payroll Deductions and All Required Withholdings. Target Bonus
12/34/56
EX-10.5
from 10-Q ~5 pages Amended and Restated Portola Pharmaceuticals, Inc. Non-Employee Director Compensation Policy
12/34/56
EX-10.52
from 10-Q 10 pages Material contract
12/34/56
EX-10.51
from 10-Q 7 pages Sixth Amendment to Lease
12/34/56
EX-10.5
from 10-Q 3 pages Amended and Restated Portola Pharmaceuticals, Inc. Non-Employee Director Compensation Policy
12/34/56
EX-10.50
from 10-Q 7 pages Consulting Agreement Effective Date: March 28, 2019
12/34/56
EX-10.49
from 10-Q 3 pages You Will Be Eligible to Receive an Annual Bonus Target of 45% of Your Base Salary. Whether Portola Awards Bonuses for Any Given Year, the Allocation of the Bonuses, if Awarded, Will Be in the Sole Discretion of the Company as Determined by Its Board of Directors (The ‘‘Board”). if the Board Approves Payment of Bonuses for Any Given Year, the Bonus Amounts Generally Will Be Determined and Paid Within the First Calendar Quarter of the Year Based on the Prior Year's Performance. if Your Employment Terminates for Any Reason Prior to the Payment of a Bonus, Then You Will Not Have Earned the Bonus and Will Not Receive Any Portion of It. Equity
12/34/56
EX-10.48
from 10-Q 4 pages On Behalf of Portola Pharmaceuticals, Inc. (‘‘Portola” or the ‘‘Company”), I Am Pleased to Offer You an Exempt Position of Executive Vice President, Chief Human Resources Officer, Reporting to John Curnutte, Co-President and Executive Vice President, R&D. Upon the Arrival of the New Chief Executive Officer, You Will Report to the Chief Executive Officer. Your Start Date for This Position Is Monday, August 20, 2018. Annual Salary Your Salary Will Be Paid at the Rate of $35,000.00 Per Month ($420,000.00 Annualized) Less Payroll Deductions and All Required Withholdings. Target Bonus
12/34/56
EX-10.47
from 10-Q 60 pages Manufacturing Services Agreement
12/34/56
EX-10.28
from 10-Q 21 pages Amended and Restated Portola Pharmaceuticals, Inc. Inducement Plan Adopted by the Board of Directors: July 9, 2017 Amended and Restated by the Board of Directors: December 14, 2018
12/34/56
EX-10.3
from 10-Q 28 pages Portola Pharmaceuticals, Inc. 2013 Equity Incentive Plan Adopted by the Board of Directors: January 30, 2013 Ipo Date/Effective Date: May 21, 2013
12/34/56
EX-10.28
from 10-K 20 pages Amended and Restated Portola Pharmaceuticals, Inc. Inducement Plan Adopted by the Board of Directors: July 9, 2017 Amended and Restated by the Board of Directors: December 14, 2018
12/34/56
EX-10.44
from 10-Q 4 pages B.CONSULTING Services. as a Consultant, You Will Be Responsible for Assisting the Company in Any Area of Your Expertise, as Reasonably Requested by the Company (The “Consulting Services”), Not to Exceed One (1) Day Per Week or Forty (40) Hours Per Month. You Will Conduct the Consulting Services at a Location and During Times to Be Mutually Agreed Upon, and Will Exercise the Highest Degree of Professionalism. You Will Be Directed in All of Your Consulting Services by Either Interim Co-Presidents of the Company (Or Either of Their Designees). C.COMPENSATION
12/34/56
EX-10.4
from 8-K 20 pages Executive Severance Benefits Agreement
12/34/56
EX-10.43
from 8-K 3 pages September 10, 2018 Dear Scott, on Behalf of Portola Pharmaceuticals, Inc. (“Portola” or the “Company”), I Am Pleased to Offer You an Exempt Position of President and Chief Executive Officer. Your Start Date for This Position Is to Be Determined. Annual Salary Your Salary Will Be Paid at the Rate of $52,083.34 Per Month ($625,000.00 Annualized) Less Payroll Deductions and All Required Withholdings. Target Bonus
12/34/56
EX-10.42
from 10-Q 3 pages You Will Be Eligible to Receive an Annual Bonus Target of 40% of Your Base Salary. Whether Portola Awards Bonuses for Any Given Year, the Allocation of the Bonuses, if Awarded, Will Be in the Sole Discretion of the Company as Determined by Its Board of Directors (The "Board"). if the Board Approves Payment of Bonuses for Any Given Year, the Bonus Amounts Generally Will Be Determined and Paid Within the First Calendar Quarter of the Year Based on the Prior Year's Performance. if Your Employment Terminates for Any Reason Prior to the Payment of a Bonus, Then You Will Not Have Earned the Bonus and Will Not Receive Any Portion of It. Equity
12/34/56
EX-10.41
from 10-Q 3 pages You Will Be Eligible to Receive an Annual Bonus Target of 45% of Your Base Salary. Whether Portola Awards Bonuses for Any Given Year, the Allocation of the Bonuses, if Awarded, Will Be in the Sole Discretion of the Company as Determined by Its Board of Directors (The "Board"). if the Board Approves Payment of Bonuses for Any Given Year, the Bonus Amounts Generally Will Be Determined and Paid Within the First Calendar Quarter of the Year Based on the Prior Year's Performance. if Your Employment Terminates for Any Reason Prior to the End of the Calendar Year, Then You Will Not Have Earned a Bonus for That Year and Will Not Receive Any Portion of It. Equity
12/34/56
EX-10.40
from 10-Q 3 pages On Behalf of Portola Pharmaceuticals, Inc. (“Portola” or the “Company”), I Am Pleased to Offer You an Exempt Position of Senior Vice President, Chief Medical Officer Reporting to Bill Lis, Chief Executive Officer. Your “Home” Office and Primary Work Location Will Be Your Personal Residence in New Jersey, and Your Will Be Required to Make Regular Business Trips to Headquarters in California. Your Start Date for This Position Is Monday, November 6, 2017. Annual Salary Your Salary Will Be Paid at the Rate of $35,833.34 Per Month ($430,000.00 Annualized) Less Payroll Deductions and All Required Withholdings. Target Bonus
12/34/56
EX-10.39
from 10-Q 2 pages June 3, 2018 John Moriarty Portola Pharmaceuticals, Inc. 270 East Grand Avenue South San Francisco, Ca 94080 Dear John: As You Know, Portola Pharmaceuticals, Inc. (The "Company") Is Initiating a Search for a New Chief Executive Officer. in Order to Provide You With Enhanced Security During This Period of Time, the Company Is Offering You the Following Benefits
12/34/56
EX-10.38
from 10-Q 1 page June 3, 2018 John (Jack) Lawrence Portola Pharmaceuticals, Inc. 270 East Grand Avenue South San Francisco, Ca 94080 Dear Jack
12/34/56